Glycoengineered cell models for the characterization of cancer O-glycoproteome: an innovative strategy for biomarker discovery

References

• Varki A, Cummings RD. In: Varki A, Cummings RD, Esko JD, et al. editors. Essentials of glycobiology. Cold Spring Harbor; NY: 2009
   Google Scholar
• Spiro RG. Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds. Glycobiology 2002;12(4):43R-56R
   PubMed Web of Science ®Google Scholar
• Bennett EP, Mandel U, Clausen H, et al. Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family. Glycobiology 2012;22(6):736-56
   PubMed Web of Science ®Google Scholar
• Clausen H, Bennett EP. A family of UDP-GalNAc: polypeptide N-acetylgalactosaminyl-transferases control the initiation of mucin-type O-linked glycosylation. Glycobiology 1996;6(6):635-46
   PubMed Web of Science ®Google Scholar
• Kong Y, Joshi HJ, Schjoldager KT, et al. Probing polypeptide GalNAc-transferase isoform substrate specificities by in vitro analysis. Glycobiology 2015;25(1):55-65
   PubMed Web of Science ®Google Scholar
• Brockhausen I, Yang J, Lehotay M, et al. Pathways of mucin O-glycosylation in normal and malignant rat colonic epithelial cells reveal a mechanism for cancer-associated Sialyl-Tn antigen expression. Biol Chem 2001;382(2):219-32
   PubMedGoogle Scholar
• Ju T, Lanneau GS, Gautam T, et al. Human tumor antigens Tn and sialyl Tn arise from mutations in Cosmc. Cancer Res 2008;68(6):1636-46
   PubMed Web of Science ®Google Scholar
• Cazet A, Julien S, Bobowski M, et al. Tumour-associated carbohydrate antigens in breast cancer. Breast Cancer Res 2010;12(3):204
   PubMed Web of Science ®Google Scholar
• Itzkowitz S, Kjeldsen T, Friera A, et al. Expression of Tn, sialosyl Tn, and T antigens in human pancreas. Gastroenterology 1991;100(6):1691-700
   PubMed Web of Science ®Google Scholar
• Pinho SS, Carvalho S, Marcos-Pinto R, et al. Gastric cancer: adding glycosylation to the equation. Trends Mol Med 2013;19(11):664-76
   PubMedGoogle Scholar
• Wahrenbrock MG, Varki A. Multiple hepatic receptors cooperate to eliminate secretory mucins aberrantly entering the bloodstream: are circulating cancer mucins the “tip of the iceberg”? Cancer Res 2006;66(4):2433-41
   PubMed Web of Science ®Google Scholar
• Chen K, Gentry-Maharaj A, Burnell M, et al. Microarray Glycoprofiling of CA125 improves differential diagnosis of ovarian cancer. J Proteome Res 2013;12(3):1408-18
   PubMed Web of Science ®Google Scholar
• Gomes C, Almeida A, Ferreira JA, et al. Glycoproteomic analysis of serum from patients with gastric precancerous lesions. J Proteome Res 2013;12(3):1454-66
   PubMed Web of Science ®Google Scholar
• Wandall HH, Blixt O, Tarp MA, et al. Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes. Cancer Res 2010;70(4):1306-13
   PubMed Web of Science ®Google Scholar
• Ychou M, Duffour J, Kramar A, et al. Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer. Dis Markers 2000;16(3-4):105-10
   PubMedGoogle Scholar
• Magnani JL, Steplewski Z, Koprowski H, Ginsburg V. Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin. Cancer Res 1983;43(11):5489-92
   PubMed Web of Science ®Google Scholar
• Guadagni F, Roselli M, Amato T, et al. Clinical evaluation of serum tumor-associated glycoprotein-72 as a novel tumor marker for colorectal cancer patients. J Surg Oncol Suppl 1991;2:16-20
   PubMedGoogle Scholar
• Guadagni F, Roselli M, Cosimelli M, et al. TAG-72 (CA 72-4 assay) as a complementary serum tumor antigen to carcinoembryonic antigen in monitoring patients with colorectal cancer. Cancer 1993;72(7):2098-106
   PubMedGoogle Scholar
• Kjeldsen T, Clausen H, Hirohashi S, et al. Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2----6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope. Cancer Res 1998;048(8):2214-20
   Google Scholar
• Marcos NT, Bennett EP, Gomes J, et al. ST6GalNAc-I controls expression of sialyl-Tn antigen in gastrointestinal tissues. Front Biosci (Elite Ed) 2011;3:1443-55
   PubMedGoogle Scholar
• Marcos NT, Pinho S, Grandela C, et al. Role of the human ST6GalNAc-I and ST6GalNAc-II in the synthesis of the cancer-associated sialyl-Tn antigen. Cancer Res 2004;64(19):7050-7
   PubMed Web of Science ®Google Scholar
• Sewell R, Backstrom M, Dalziel M, et al. The ST6GalNAc-I sialyltransferase localizes throughout the Golgi and is responsible for the synthesis of the tumor-associated sialyl-Tn O-glycan in human breast cancer. J Biol Chem 2006;281(6):3586-94
   PubMed Web of Science ®Google Scholar
• Ju T, Aryal RP, Stowell CJ, Cummings RD. Regulation of protein O-glycosylation by the endoplasmic reticulum-localized molecular chaperone Cosmc. J Cell Biol 2008;182(3):531-42
   PubMedGoogle Scholar
• Ju T, Cummings RD. A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta 3-galactosyltransferase. Proc Natl Acad Sci USA 2002;99(26):16613-18
   PubMed Web of Science ®Google Scholar
• Ju T, Cummings RD. Protein glycosylation: chaperone mutation in Tn syndrome. Nature 2005;437(7063):1252
   PubMedGoogle Scholar
• Radhakrishnan P, Dabelsteen S, Madsen FB, et al. Immature truncated O-glycophenotype of cancer directly induces oncogenic features. Proc Natl Acad Sci USA 2014;111(39):E4066-75
   PubMed Web of Science ®Google Scholar
• Axelsson MA, Karlsson NG, Steel DM, et al. Neutralization of pH in the Golgi apparatus causes redistribution of glycosyltransferases and changes in the O-glycosylation of mucins. Glycobiology 2001;11(8):633-44
   PubMedGoogle Scholar
• Gill DJ, Tham KM, Chia J, et al. Initiation of GalNAc-type O-glycosylation in the endoplasmic reticulum promotes cancer cell invasiveness. Proc Natl Acad Sci USA 2013;110(34):E3152-61
   PubMed Web of Science ®Google Scholar
• Steentoft C, Bennett EP, Schjoldager KT, et al. Precision genome editing: a small revolution for glycobiology. Glycobiology 2014;24(8):663-80
   PubMedGoogle Scholar
• Steentoft C, Vakhrushev SY, Joshi HJ, et al. Precision mapping of the human O-GalNAc glycoproteome through SimpleCell technology. EMBO J 2013;32(10):1478-88
   PubMed Web of Science ®Google Scholar
• Steentoft C, Vakhrushev SY, Vester-Christensen MB, et al. Mining the O-glycoproteome using zinc-finger nuclease-glycoengineered SimpleCell lines. Nat Methods 2011;8(11):977-82
   PubMedGoogle Scholar
• Schjoldager KT, Vakhrushev SY, Kong Y, et al. Probing isoform-specific functions of polypeptide GalNAc-transferases using zinc finger nuclease glycoengineered SimpleCells. Proc Natl Acad Sci USA 2012;109(25):9893-8
   PubMedGoogle Scholar
• Vakhrushev SY, Steentoft C, Vester-Christensen MB, et al. Enhanced mass spectrometric mapping of the human GalNAc-type O-glycoproteome with SimpleCells. Mol Cell Proteomics 2013;12(4):932-44
   PubMed Web of Science ®Google Scholar
• Dube DH, Prescher JA, Quang CN, Bertozzi CR. Probing mucin-type O-linked glycosylation in living animals. Proc Natl Acad Sci USA 2006;103(13):4819-24
   PubMed Web of Science ®Google Scholar
• Hang HC, Yu C, Kato DL, Bertozzi CR. A metabolic labeling approach toward proteomic analysis of mucin-type O-linked glycosylation. Proc Natl Acad Sci USA 2003;100(25):14846-51
   PubMed Web of Science ®Google Scholar
• Levery SB, Steentoft C, Halim A, et al. Advances in mass spectrometry driven O-glycoproteomics. Biochim Biophys Acta 2015;1850(1):33-42
   PubMed Web of Science ®Google Scholar
• Schjoldager KT, Clausen H. Site-specific protein O-glycosylation modulates proprotein processing - deciphering specific functions of the large polypeptide GalNAc-transferase gene family. Biochim Biophys Acta 2012;1820(12):2079-94
   PubMed Web of Science ®Google Scholar
• Vester-Christensen MB, Halim A, Joshi HJ, et al. Mining the O-mannose glycoproteome reveals cadherins as major O-mannosylated glycoproteins. Proc Natl Acad Sci USA 2013;110(52):21018-23
   PubMed Web of Science ®Google Scholar
• Campos D, Freitas D, Gomes J, et al. Probing the O-glycoproteome of gastric cancer cell lines for biomarker discovery. Mol Cell Proteomics 2015;14(6):1616-29
   PubMed Web of Science ®Google Scholar
• Surinova S, Schiess R, Huttenhain R, et al. On the development of plasma protein biomarkers. J Proteome Res 2011;10(1):5-16
   PubMed Web of Science ®Google Scholar
• Reis CA, Osorio H, Silva L, et al. Alterations in glycosylation as biomarkers for cancer detection. J Clin Pathol 2010;63(4):322-9
   PubMed Web of Science ®Google Scholar
• Drake PM, Cho W, Li B, et al. Sweetening the pot: adding glycosylation to the biomarker discovery equation. Clin Chem 2010;56(2):223-36
   PubMed Web of Science ®Google Scholar
• Madsen CB, Pedersen AE, Wandall HH. Glycan-mediated modification of the immune response. Oncoimmunology 2013;2(4):e23659
   Google Scholar